Jove
Visualize
Contact Us

Related Experiment Videos

Apoptotic cell death and lupus.

Philip L Cohen1

  • 1University of Pennsylvania, 421 Curie Boulevard, Suite 757, Philadelphia, PA 19104, USA. philipco@mail.med.upenn.edu

Springer Seminars in Immunopathology
|August 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can we cure lupus?

Current opinion in immunology·2025
Same author

Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins.

Frontiers in immunology·2023
Same author

Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?

The Lancet. Rheumatology·2020
Same author

Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model.

Journal of autoimmunity·2020
Same author

Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.

Journal of autoimmunity·2020
Same author

Gas6/TAM Receptors in Systemic Lupus Erythematosus.

Disease markers·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Programmed cell death, or apoptosis, is crucial for health. Dysregulation in apoptosis and its clearance by phagocytes may drive autoimmune diseases like lupus, suggesting new therapeutic targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathogenesis of Autoimmune Diseases

Background:

  • Programmed cell death (apoptosis) and the clearance of resulting cell corpses by phagocytes are vital physiological processes.
  • Aberrations in apoptosis susceptibility and impaired apoptotic cell clearance are implicated in human diseases, including autoimmune lymphoproliferative syndrome and systemic lupus erythematosus (SLE).
  • Apoptosis plays a role in the effector mechanisms of lupus pathogenesis.

Purpose of the Study:

  • To elucidate the multifaceted roles of apoptosis in the pathogenesis of systemic lupus erythematosus (SLE).
  • To explore the implications of dysregulated apoptosis and impaired efferocytosis in SLE.
  • To identify potential diagnostic and therapeutic strategies for SLE based on a deeper understanding of apoptosis.

Main Methods:

Related Experiment Videos

  • Review and synthesis of existing literature on programmed cell death, efferocytosis, and their connection to SLE.
  • Analysis of molecular and cellular mechanisms underlying apoptosis dysregulation in autoimmune conditions.
  • Examination of evidence linking impaired clearance of apoptotic cells to SLE pathogenesis.

Main Results:

  • Abnormalities in receptor-induced cell death susceptibility contribute to autoimmune diseases, potentially including SLE.
  • Defects in the clearance of apoptotic cells are likely significant in lupus pathogenesis, although the precise biological basis is still under investigation.
  • Apoptosis is actively involved in the disease-driving mechanisms of lupus.

Conclusions:

  • A comprehensive understanding of apoptosis's role in SLE is essential for advancing diagnostic capabilities.
  • Targeting apoptosis pathways and improving apoptotic cell clearance may offer novel therapeutic avenues for SLE.
  • Further research into the biological basis of impaired efferocytosis in SLE is warranted.